Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/05/316
Active ingredient: 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Actelion Registration Ltd
Chiswick Tower, 13th floor, 389 Chiswick High Road, London W4 4AL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Orphan designation EMEA/OD/043/05 (2005)3356 of 26/08/2005
19/02/2009 Transfer of orphan designation EMEA/OD/043/05/T/01 (2009)1185 of 17/02/2009
02/07/2014 Change of name and/or address of sponsor
22/02/2016 Removal of orphan designation from Community Register